21. November 2009 01:38
"Many Americans have a very limited understanding of the basic facts about diabetes, as well as the serious consequences for health that accompany the disease," commented Sue McLaughlin, RD, CDE, President, Health Care & Education, American Diabetes Association, in a media alert. She blames the problem on a combination of factors including denial of the disease and promotion of inaccurate information or myths surrounding diabetes.
[More]
01aaafff-2eee-49e3-abb7-2fcf60212f73|0|.0
Posted in: Medical Condition News
Tags: Blood Pressure, Blood Vessel, Breast Cancer, Cancer, Diabetes, Diet, Education, Exercise, Gestational Diabetes, Hospital, Insulin, Lipids, Obesity, Type 2 Diabetes
20. November 2009 23:40
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.
[More]
eb34af81-8141-4574-b270-52cb5d01cd03|0|.0
Posted in: Child Health News | Pharmaceutical News
Tags: Abilify, Antidepressant, Antipsychotic, Autism, Bipolar Disorder, Blood Pressure, Cardiovascular Disease, Cell, Cerebrovascular Disease, Constipation, Creatinine, Dehydration, Dementia, Depression, Diabetes, Diabetes Mellitus, Dystonia, Exercise, Heart Failure, Hyperglycemia, Hypersensitivity, Insomnia, Leukopenia, Lipids, Nausea, Neutropenia, New Drug Application, Obesity, Pediatrics, Pneumonia, Psychosis, Schizophrenia, Speech, Stroke, Tardive Dyskinesia, Urticaria, Vomiting
20. November 2009 00:59
Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc., today announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® (lubiprostone) 24 microgram (mcg) gel capsules for the long-term treatment of patients with chronic idiopathic constipation (CIC).
[More]
17. November 2009 10:42
Genzyme Corp. and Isis Pharmaceuticals Inc. announced that data from the phase 3 study of mipomersen in patients with homozygous familial hypercholesterolemia (hoFH) were presented today at the American Heart Association’s Scientific Sessions.
[More]
1a400a77-bfd0-472a-9ee1-b2297389c9de|0|.0
Posted in: Drug Trial News | Medical Condition News
Tags: Antisense, Atherosclerosis, Biotechnology, Cancer, Carbohydrate, Cardiovascular Disease, Cholesterol, Coronary Heart Disease, Hypercholesterolemia, Kidney Disease, Lipids, Lipoprotein, Metabolism, microRNA, Statin, Transplant
16. November 2009 07:55
PanGenex Corporation, a global nutraceutical and dietary supplement manufacturer and marketer, announced today that it has finalized a strategic partnership with BulovaTech Labs, Inc., (“LABS”), a wholly-owned subsidiary of Bulova Technologies Group Inc.
[More]
16. November 2009 00:14
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
[More]
13. November 2009 04:32
The lipid that accumulates in brain cells of individuals with an inherited enzyme disorder also drives the cell death that is a hallmark of the disease, according to new research led by St. Jude Children's Research Hospital investigators.
[More]
7501fbda-21c9-4921-9a80-48c8acc10ef9|0|.0
Posted in: Medical Science News | Medical Condition News
Tags: Apoptosis, Brain, Calcium, Cancer, Cell, Gene Therapy, Genetics, Hospital, Lipids, Neurodegeneration, Protein Folding
12. November 2009 08:27
A new study from the University of Warwick has discovered taking too much of the essential mineral selenium in your diet can increase your cholesterol by almost 10%.
[More]
12. November 2009 08:09
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, is providing an update on its RNAi pipeline, platform, and technology at its R&D Day being held in New York today.
[More]
5036496b-89df-4bea-8d18-fd46448e0878|0|.0
Posted in: Medical Science News
Tags: Cardiomyopathy, Cell, Hospital, Hypercholesterolemia, Lipids, microRNA, Neuropathy, Physiology, RNAi Therapeutics, siRNA, Transplant, Virus
11. November 2009 04:51
Lipid assessment in vascular disease can be simplified by measuring either total and HDL cholesterol levels or apolipoproteins, without the need to fast and without regard to triglyceride levels, according to a study in the November 11 issue of JAMA.
[More]
11. November 2009 03:46
For many people, diet and exercise help keep them looking and feeling healthy. But even those who work hard on staying in shape might have a hard time shaking stubborn love handles or lower belly fat, which can bulge through clothing like a neon sign. While the market for getting rid of unwanted fat has grown over the years to include stomach stapling and behavioral techniques, there is still a demand for procedures that can reduce areas of localized fat safely and effectively.
[More]
10. November 2009 04:04
A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine.
[More]
6. November 2009 03:06
Most biopsies following mammograms reveal benign abnormalities, not cancer.
[More]
5. November 2009 01:01
Inspire Pharmaceuticals, Inc. announced today patient enrollment is complete in three of its late-stage clinical trials.
[More]
4. November 2009 22:57
Although statins are widely used to prevent heart attacks, strokes, and other cardiovascular disorders, new research shows that the class of drugs may actually have negative effects on some cardiac patients. A new study presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that statins have beneficial effects on patients with systolic heart failure (SHF), but those with diastolic heart failure (DHF) experienced the opposite effect, including increased dyspnea, fatigue, and decreased exercise tolerance.
[More]
70a525db-6506-46bf-8f06-319b2129bcba|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Anti-Inflammatory, Atorvastatin, Cardiovascular Disease, Cholesterol, Coronary Artery Disease, Dyspnea, Education, Exercise, Heart Failure, Hospital, Lipids, Sleep, Statin